A new trading day began on Friday, with Macrogenics Inc (NASDAQ: MGNX) stock price down -4.46% from the previous day of trading, before settling in for the closing price of $1.57. MGNX’s price has ranged from $0.99 to $3.60 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 19.47%. Meanwhile, its annual earnings per share averaged -22.44%. With a float of $58.15 million, this company’s outstanding shares have now reached $63.26 million.
Macrogenics Inc (MGNX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Macrogenics Inc is 8.07%, while institutional ownership is 68.76%. The most recent insider transaction that took place on Aug 19 ’25, was worth 76,760. In this transaction Director of this company bought 50,500 shares at a rate of $1.52, taking the stock ownership to the 61,500 shares. Before that another transaction happened on Aug 20 ’25, when Company’s Director bought 49,500 for $1.49, making the entire transaction worth $73,755. This insider now owns 111,000 shares in total.
Macrogenics Inc (MGNX) Earnings and Forecasts
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.82 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.65 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -22.44% per share during the next fiscal year.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Here are Macrogenics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.21, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -1.73 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Looking closely at Macrogenics Inc (NASDAQ: MGNX), its last 5-days average volume was 4.22 million, which is a jump from its year-to-date volume of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 71.45%.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 22.58%, which indicates a significant decrease from 52.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1027 in the past 14 days, which was lower than the 0.1232 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5445, while its 200-day Moving Average is $1.5818. However, in the short run, Macrogenics Inc’s stock first resistance to watch stands at $1.5733. Second resistance stands at $1.6467. The third major resistance level sits at $1.6833. If the price goes on to break the first support level at $1.4633, it is likely to go to the next support level at $1.4267. Should the price break the second support level, the third support level stands at $1.3533.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
With a market capitalization of 94.89 million, the company has a total of 63,259K Shares Outstanding. Currently, annual sales are 149,960 K while annual income is -66,970 K. The company’s previous quarter sales were 72,840 K while its latest quarter income was 16,820 K.
